Matches in Wikidata for { <http://www.wikidata.org/entity/Q64170817> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q64170817 description "clinical trial" @default.
- Q64170817 description "ensayu clínicu" @default.
- Q64170817 description "klinisch onderzoek" @default.
- Q64170817 description "клінічне випробування" @default.
- Q64170817 description "կլինիկական փորձարկում" @default.
- Q64170817 name "Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission" @default.
- Q64170817 type Item @default.
- Q64170817 label "Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission" @default.
- Q64170817 prefLabel "Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission" @default.
- Q64170817 P1132 Q64170817-20B83E1B-F8B8-4B3B-8A24-203837C80767 @default.
- Q64170817 P131 Q64170817-BB03128A-BAB7-47F5-8AFF-54590D345927 @default.
- Q64170817 P1476 Q64170817-F75A5475-FD7B-4B2E-BAFD-8A39EA575F33 @default.
- Q64170817 P17 Q64170817-209AF13B-00B9-4D56-AEAC-47438BCC2713 @default.
- Q64170817 P17 Q64170817-58025036-FE93-4EAA-9BD9-011E657FFF3F @default.
- Q64170817 P17 Q64170817-6B26E3C5-1EBB-4D9B-BCEC-5938204987C1 @default.
- Q64170817 P17 Q64170817-9BE138F7-CFC6-47CD-A821-F862432EF21E @default.
- Q64170817 P17 Q64170817-D4D96B0D-9F4B-4FAF-9277-A22509513317 @default.
- Q64170817 P17 Q64170817-D774A2D1-858D-487E-A5BB-719FF26C8D6A @default.
- Q64170817 P2899 Q64170817-0106B3B2-D911-4DDD-BCDD-84ED73CCBE27 @default.
- Q64170817 P3098 Q64170817-D06174F9-1E8F-4182-ADA8-F528B3FB733D @default.
- Q64170817 P31 Q64170817-A443E113-0B06-439E-AB47-D8266716C9F2 @default.
- Q64170817 P4844 Q64170817-C7052FFF-590F-48ED-A45E-8C159E6F5295 @default.
- Q64170817 P580 Q64170817-3F691FFD-2D60-4C41-9843-FAB8BA222156 @default.
- Q64170817 P582 Q64170817-F0DAF34D-6EEF-460F-AFD2-2D23516EBD16 @default.
- Q64170817 P6099 Q64170817-706BC2D1-D1DD-4BBE-8EFB-9836E1A1FC3A @default.
- Q64170817 P6153 Q64170817-B6417475-1E0B-4B46-B055-21B33D421F03 @default.
- Q64170817 P6153 Q64170817-BBA2CC23-6FEC-4DD9-AAA4-C01FFBABAAD5 @default.
- Q64170817 P8363 Q64170817-DDF9ADB5-ABE9-4E8C-93C7-1774AAC31CBA @default.
- Q64170817 P1132 "+394" @default.
- Q64170817 P131 Q1183 @default.
- Q64170817 P1476 "A Phase IV Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Two Different Potent Regimens in HIV Infected Women Initiating Triple Antiretroviral Regimens Between 20 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission: NICHD P1081" @default.
- Q64170817 P17 Q155 @default.
- Q64170817 P17 Q258 @default.
- Q64170817 P17 Q30 @default.
- Q64170817 P17 Q414 @default.
- Q64170817 P17 Q869 @default.
- Q64170817 P17 Q924 @default.
- Q64170817 P2899 "+16" @default.
- Q64170817 P3098 "NCT01618305" @default.
- Q64170817 P31 Q30612 @default.
- Q64170817 P4844 Q198504 @default.
- Q64170817 P580 "2013-07-01T00:00:00Z" @default.
- Q64170817 P582 "2018-12-11T00:00:00Z" @default.
- Q64170817 P6099 Q42825046 @default.
- Q64170817 P6153 Q1193547 @default.
- Q64170817 P6153 Q13026856 @default.
- Q64170817 P8363 Q78089383 @default.